These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22791756)

  • 1. A new combination of testosterone and nestorone transdermal gels for male hormonal contraception.
    Ilani N; Roth MY; Amory JK; Swerdloff RS; Dart C; Page ST; Bremner WJ; Sitruk-Ware R; Kumar N; Blithe DL; Wang C
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3476-86. PubMed ID: 22791756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men.
    Mahabadi V; Amory JK; Swerdloff RS; Bremner WJ; Page ST; Sitruk-Ware R; Christensen PD; Kumar N; Tsong YY; Blithe D; Wang C
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2313-20. PubMed ID: 19366848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined nestorone-testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men.
    Anawalt BD; Roth MY; Ceponis J; Surampudi V; Amory JK; Swerdloff RS; Liu PY; Dart C; Bremner WJ; Sitruk-Ware R; Kumar N; Blithe DL; Page ST; Wang C
    Andrology; 2019 Nov; 7(6):878-887. PubMed ID: 30969032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trial.
    Roth MY; Shih G; Ilani N; Wang C; Page ST; Bremner WJ; Swerdloff RS; Sitruk-Ware R; Blithe DL; Amory JK
    Contraception; 2014 Oct; 90(4):407-12. PubMed ID: 24981149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of various progestins with or without transdermal testosterone on gonadotropin levels for non-invasive hormonal male contraception: a randomized clinical trial.
    Zitzmann M; Rohayem J; Raidt J; Kliesch S; Kumar N; Sitruk-Ware R; Nieschlag E
    Andrology; 2017 May; 5(3):516-526. PubMed ID: 28189123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing secondary exposure to women from men applying a novel nestorone/testosterone contraceptive gel.
    Yuen F; Wu S; Thirumalai A; Swerdloff RS; Page ST; Liu PY; Dart C; Wu H; Blithe DL; Sitruk-Ware R; Long J; Bai F; Hull L; Bremner WJ; Anawalt BD; Wang C
    Andrology; 2019 Mar; 7(2):235-243. PubMed ID: 30556332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
    Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics associated with suppression of spermatogenesis in a male hormonal contraceptive trial using testosterone and Nestorone(®) gels.
    Roth MY; Ilani N; Wang C; Page ST; Bremner WJ; Swerdloff RS; Dart C; Sitruk-Ware R; Kumar N; Blithe D; Amory JK
    Andrology; 2013 Nov; 1(6):899-905. PubMed ID: 24123845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist.
    Page ST; Amory JK; Anawalt BD; Irwig MS; Brockenbrough AT; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4374-80. PubMed ID: 16940442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-finding, cross-over study to evaluate the effect of a Nestorone®/Estradiol transdermal gel delivery on ovulation suppression in normal ovulating women.
    Brache V; Merkatz R; Kumar N; Jesam C; Sussman H; Hoskin E; Roberts K; Alami M; Taylor D; Jorge A; Croxatto H; Lorange E; Mishell DR; Sitruk-Ware R
    Contraception; 2015 Oct; 92(4):289-97. PubMed ID: 26032952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of an international male contraceptive efficacy trial using a self-administered daily transdermal gel containing testosterone and segesterone acetate (Nestorone).
    Amory JK; Blithe DL; Sitruk-Ware R; Swerdloff RS; Bremner WJ; Dart C; Liu PY; Thirumalai A; Nguyen BT; Anawalt BD; Lee MS; Page ST; Wang C
    Contraception; 2023 Aug; 124():110064. PubMed ID: 37210024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
    Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
    J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
    Guerin JF; Rollet J
    Int J Androl; 1988 Jun; 11(3):187-99. PubMed ID: 2970439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An initial pharmacokinetic study with a Metered Dose Transdermal Systemfor delivery of the progestogen Nestorone as a possible future contraceptive.
    Fraser IS; Weisberg E; Kumar N; Kumar S; Humberstone AJ; McCrossin L; Shaw D; Tsong YY; Sitruk-Ware R
    Contraception; 2007 Dec; 76(6):432-8. PubMed ID: 18061700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of new hormonal male contraception for the couple.
    Kroopnick JM; Lee MS; Blithe DL
    Andrology; 2024 Oct; 12(7):1506-1511. PubMed ID: 38745531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contraceptive efficacy and clinical performance of Nestorone implants in postpartum women.
    Massai MR; Díaz S; Quinteros E; Reyes MV; Herreros C; Zepeda A; Croxatto HB; Moo-Young AJ
    Contraception; 2001 Dec; 64(6):369-76. PubMed ID: 11834236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men.
    Behre HM; Zitzmann M; Anderson RA; Handelsman DJ; Lestari SW; McLachlan RI; Meriggiola MC; Misro MM; Noe G; Wu FC; Festin MP; Habib NA; Vogelsong KM; Callahan MM; Linton KA; Colvard DS
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4779-4788. PubMed ID: 27788052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese men.
    Wang C; Wang XH; Nelson AL; Lee KK; Cui YG; Tong JS; Berman N; Lumbreras L; Leung A; Hull L; Desai S; Swerdloff RS
    J Clin Endocrinol Metab; 2006 Feb; 91(2):460-70. PubMed ID: 16278260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen.
    Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Sivin I; Tsong YY; Fraser IS
    Contraception; 2005 Jul; 72(1):46-52. PubMed ID: 15964292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.